ENTITY
Ilyang Pharmaceutical Co.,

Ilyang Pharmaceutical Co., (007570 KS)

33
Analysis
Health CareSouth Korea
Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system. The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food, insecticides, cosmetics, pharmaceutical raw materials, and therapeutic agents for liver and kidney disease.
more
bullishHanjin KAL Corp
01 Mar 2020 12:14

KOSPI200 Rebalance Preview - Changing Names in a Volatile Market

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
383 Views
Share
bullishPosco Future M
10 Feb 2020 13:01

KOSPI200 Rebalance Preview - The Early Bird Gets the Worm

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
520 Views
Share
bearishCelltrion Inc
10 Aug 2017 19:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.4k Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.4k Views
Share
x